Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
Regeneron Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 26, 2019
Regeneron Pharmaceuticals reported fiscal year 2018 executive compensation information on April 26, 2019.
In 2018, five executives at Regeneron Pharmaceuticals received on average a compensation package of $16M, a 2% decrease compared to previous year.
Average pay of disclosed executives at Regeneron Pharmaceuticals
Leonard S. Schleifer, Chief Executive Officer, received $27M in total, which is about the same as previous year. 80% of Schleifer's compensation, or $21M, was in option awards. Schleifer also received $3M in non-equity incentive plan, $1.3M in salary, as well as $896K in other compensation.
George D. Yancopoulos, Chief Scientific Officer, received a compensation package of $25M, which is about the same as previous year. 84% of the compensation package, or $21M, was in option awards.
Marion McCourt, Senior Vice President, Commercial, earned $10M in 2018.
Robert E. Landry, Chief Financial Officer, received $9.4M in 2018, which increases by 95% compared to 2017.
Daniel Van Plew, Executive Vice President and General Manager, Industrial Operations and Product Supply, earned $9M in 2018, which is about the same as previous year.
Related executives
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
Marion McCourt
Regeneron Pharmaceuticals
Senior Vice President, Commercial
You may also like
Source: SEC filing on April 26, 2019.